<s id="wsj_1242.1"> 27
3 	 0 	 N/N 	 1 	 Inc. Bausch
3 	 1 	 N/N 	 1 	 Inc. &
3 	 2 	 N/N 	 1 	 Inc. Lomb
3 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. said
7 	 5 	 NP[nb]/N 	 1 	 subsidiary its
7 	 6 	 N/N 	 1 	 subsidiary pharmaceuticals
7 	 8 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 subsidiary agreed
7 	 10 	 ((S[b]\NP)/PP)/NP 	 1 	 subsidiary supply <XB>
8 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 agreed said
9 	 8 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to agreed
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 supply to
13 	 10 	 ((S[b]\NP)/PP)/NP 	 3 	 shields supply
13 	 11 	 N/N 	 1 	 shields collagen
13 	 12 	 N/N 	 1 	 shields corneal
13 	 14 	 (NP\NP)/NP 	 1 	 shields for
17 	 14 	 (NP\NP)/NP 	 2 	 surgery for
17 	 15 	 N/N 	 1 	 surgery animal
17 	 16 	 N/N 	 1 	 surgery eye
18 	 10 	 ((S[b]\NP)/PP)/NP 	 2 	 to supply
20 	 18 	 PP/NP 	 1 	 unit to
20 	 19 	 NP[nb]/N 	 1 	 unit a
20 	 21 	 (NP\NP)/NP 	 1 	 unit of
26 	 21 	 (NP\NP)/NP 	 2 	 Corp of
26 	 22 	 N/N 	 1 	 Corp International
26 	 23 	 N/N 	 1 	 Corp Minerals
26 	 24 	 N/N 	 1 	 Corp &
26 	 25 	 N/N 	 1 	 Corp Chemical
<\s>
<s id="wsj_1242.2"> 4
0 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Terms were
0 	 3 	 S[pss]\NP 	 1 	 Terms disclosed <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 were n't
3 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 disclosed were
<\s>
<s id="wsj_1242.3"> 18
1 	 0 	 NP[nb]/N 	 1 	 agreement The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 agreement marks
5 	 3 	 N/N 	 1 	 Lomb Bausch
5 	 4 	 N/N 	 1 	 Lomb &
5 	 6 	 (NP[nb]/N)\NP 	 2 	 Lomb 's
8 	 2 	 (S[dcl]\NP)/NP 	 2 	 venture marks
8 	 6 	 (NP[nb]/N)\NP 	 1 	 venture 's
8 	 7 	 N/N 	 1 	 venture first
8 	 9 	 (S[ng]\NP)/NP 	 1 	 venture selling <XB>
9 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 selling for
13 	 9 	 (S[ng]\NP)/NP 	 2 	 products selling
13 	 10 	 NP[nb]/N 	 1 	 products its
13 	 11 	 N/N 	 1 	 products eye
13 	 12 	 N/N 	 1 	 products care
15 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 use for
15 	 16 	 (NP\NP)/NP 	 1 	 use by
17 	 16 	 (NP\NP)/NP 	 2 	 veterinarians by
<\s>
<s id="wsj_1242.4"> 13
3 	 0 	 NP[nb]/N 	 1 	 shield The
3 	 1 	 N/N 	 1 	 shield collagen
3 	 2 	 N/N 	 1 	 shield corneal
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 shield helps
3 	 5 	 (S[b]\NP)/NP 	 1 	 shield speed <XB>
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 speed helps
6 	 5 	 (S[b]\NP)/NP 	 2 	 healing speed
6 	 7 	 (NP\NP)/NP 	 1 	 healing of
6 	 10 	 (NP\NP)/NP 	 1 	 healing after
9 	 7 	 (NP\NP)/NP 	 2 	 cornea of
9 	 8 	 NP[nb]/N 	 1 	 cornea the
12 	 10 	 (NP\NP)/NP 	 2 	 surgery after
12 	 11 	 N/N 	 1 	 surgery eye
<\s>
<s id="wsj_1242.5"> 14
1 	 0 	 NP[nb]/N 	 1 	 product The
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 product will
1 	 4 	 S[pss]\NP 	 1 	 product distributed <XB>
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
4 	 3 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 distributed be
4 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 distributed by
7 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc. by
7 	 6 	 N/N 	 1 	 Inc. Pitman-Moore
10 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 subsidiary by
10 	 9 	 NP[nb]/N 	 1 	 subsidiary a
10 	 11 	 (NP\NP)/NP 	 1 	 subsidiary of
13 	 11 	 (NP\NP)/NP 	 2 	 Minerals of
13 	 12 	 N/N 	 1 	 Minerals International
<\s>
